ArticleJournal of oncology2021

Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence.

Lemeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.